Variational AI

Founded in 2019 or earlier, Variational AI specializes in utilizing cutting-edge generative AI technology to facilitate drug discovery. The company works alongside biopharmaceutical companies to innovate new therapeutics targeting a range of diseases, with the goal of improving patient outcomes. Their Enkiâ„¢ Platform serves as a commercially viable foundation model for small molecule development, built on extensive experimental datasets. Variational AI excels in rapidly generating unique and selective lead compounds without the need for preliminary data, utilizing the Target Product Profile (TPP) to guide their efforts.

Research & Insights